STUDY OBJECTIVES: To validate the Multiple Suggested Immobilization Test (m-SIT), a symptom-provocation test measuring restless legs syndrome (RLS) severity multiple times a day while the patient is awake and resting under controlled conditions. The m-SIT was designed to overcome some limitations in measuring RLS severity with rating scales. DESIGN: Patients completed two m-SITs on 2 consecutive days while on 24-h dopaminergic medication. After treatment discontinuation, they completed one more m-SIT 3 days later. Controls performed only one m-SIT. SETTING: Sleep laboratory. PARTICIPANTS: Nineteen patients with RLS and 10 healthy controls. INTERVENTIONS: The original m-SIT consisted of seven modified 60-min SITs performed every 2 h between noon and midnight. During each SIT, the subject reclined quietly but could move his or her legs without restriction to alleviate symptoms. Every 10 min, periodic leg movements during wakefulness (PLMW) were evaluated and the m-SIT Disturbance Scale (m-SIT-DS; range 0-10) was completed. MEASUREMENTS AND RESULTS: The m-SIT, composed of 6:00pm, 8:00pm, 10:00pm, and 12:00pm SITs, discriminated patients from controls (mean m-SIT-DS: 2.68 ± 2.35 versus 0.08 ± 0.26; mean PLMW/h, P = 0.0001) and between treatment groups (on medication versus taken off medication; mean m-SIT-DS, P = 0.0001; mean PLMW/h, P < 0.01). It proved reliable on retest and covariated well with the International Restless Legs Scale (IRLS) and scales measuring daytime symptoms (Spearman ρ > 0.4). CONCLUSIONS: The m-SIT is a valid and reliable test to evaluate RLS severity and treatment response, and could be useful in the future to confirm diagnosis and identify daytime symptoms. Although it was primarily designed for clinical trials, it might be useful in clinical settings because it provides a standardized testing condition to measure RLS symptoms. CITATION: Garcia-Borreguero D; Kohnen R; Boothby L; Tzonova D; Larrosa O; Dunkl E. Validation of the Multiple Suggested Immobilization Test: a test for the assessment of severity of restless legs syndrome (Willis-Ekbom disease). SLEEP 2013;36(7):1101-1109.
STUDY OBJECTIVES: To validate the Multiple Suggested Immobilization Test (m-SIT), a symptom-provocation test measuring restless legs syndrome (RLS) severity multiple times a day while the patient is awake and resting under controlled conditions. The m-SIT was designed to overcome some limitations in measuring RLS severity with rating scales. DESIGN: Patients completed two m-SITs on 2 consecutive days while on 24-h dopaminergic medication. After treatment discontinuation, they completed one more m-SIT 3 days later. Controls performed only one m-SIT. SETTING: Sleep laboratory. PARTICIPANTS: Nineteen patients with RLS and 10 healthy controls. INTERVENTIONS: The original m-SIT consisted of seven modified 60-min SITs performed every 2 h between noon and midnight. During each SIT, the subject reclined quietly but could move his or her legs without restriction to alleviate symptoms. Every 10 min, periodic leg movements during wakefulness (PLMW) were evaluated and the m-SIT Disturbance Scale (m-SIT-DS; range 0-10) was completed. MEASUREMENTS AND RESULTS: The m-SIT, composed of 6:00pm, 8:00pm, 10:00pm, and 12:00pm SITs, discriminated patients from controls (mean m-SIT-DS: 2.68 ± 2.35 versus 0.08 ± 0.26; mean PLMW/h, P = 0.0001) and between treatment groups (on medication versus taken off medication; mean m-SIT-DS, P = 0.0001; mean PLMW/h, P < 0.01). It proved reliable on retest and covariated well with the International Restless Legs Scale (IRLS) and scales measuring daytime symptoms (Spearman ρ > 0.4). CONCLUSIONS: The m-SIT is a valid and reliable test to evaluate RLS severity and treatment response, and could be useful in the future to confirm diagnosis and identify daytime symptoms. Although it was primarily designed for clinical trials, it might be useful in clinical settings because it provides a standardized testing condition to measure RLS symptoms. CITATION: Garcia-Borreguero D; Kohnen R; Boothby L; Tzonova D; Larrosa O; Dunkl E. Validation of the Multiple Suggested Immobilization Test: a test for the assessment of severity of restless legs syndrome (Willis-Ekbom disease). SLEEP 2013;36(7):1101-1109.
Entities:
Keywords:
Daytime symptoms; Willis-Ekbom disease; laboratory tests; restless legs syndrome
Authors: Wayne Hening; Arthur S Walters; Richard P Allen; Jacques Montplaisir; Andrew Myers; Luigi Ferini-Strambi Journal: Sleep Med Date: 2004-05 Impact factor: 3.492
Authors: Marco Zucconi; Raffaele Ferri; Richard Allen; Paul Christian Baier; Oliviero Bruni; Sudhansu Chokroverty; Luigi Ferini-Strambi; Stephany Fulda; Diego Garcia-Borreguero; Wayne A Hening; Max Hirshkowitz; Birgit Högl; Magdolna Hornyak; Martin King; Pasquale Montagna; Liborio Parrino; Giuseppe Plazzi; Mario G Terzano Journal: Sleep Med Date: 2006-02-03 Impact factor: 3.492
Authors: Richard P Allen; Daniel Picchietti; Wayne A Hening; Claudia Trenkwalder; Arthur S Walters; Jacques Montplaisi Journal: Sleep Med Date: 2003-03 Impact factor: 3.492
Authors: Richard Allen; Philip M Becker; Richard Bogan; Markus Schmidt; Clete A Kushida; June M Fry; J Steven Poceta; David Winslow Journal: Sleep Date: 2004-08-01 Impact factor: 5.849
Authors: Ralf Kohnen; Richard P Allen; Heike Benes; Diego Garcia-Borreguero; Wayne A Hening; Karin Stiasny-Kolster; Marco Zucconi Journal: Mov Disord Date: 2007 Impact factor: 10.338
Authors: Diego García-Borreguero; Ralf Kohnen; Birgit Högl; Luigi Ferini-Strambi; Georgios M Hadjigeorgiou; Magdolna Hornyak; Al W de Weerd; Svenja Happe; Karin Stiasny-Kolster; Viola Gschliesser; Renata Egatz; Belen Cabrero; Birgit Frauscher; Claudia Trenkwalder; Wayne A Hening; Richard P Allen Journal: Sleep Med Date: 2007-05-31 Impact factor: 3.492
Authors: Jung-Won Shin; Yong Seo Koo; Byeong Uk Lee; Won Chul Shin; Sang Kun Lee; Yong Won Cho; Ki-Young Jung Journal: J Clin Sleep Med Date: 2016-08-15 Impact factor: 4.062
Authors: Katie L J Cederberg; Arthur S Walters; Amy W Amara; Tiffany J Braley; Morgan L Schuetz; Brianna G Mathison; Robert W Motl Journal: Sleep Med Date: 2021-06-16 Impact factor: 4.842
Authors: Osman S Ipsiroglu; Nadia Beyzaei; Mai Berger; Alexandra L Wagner; Sophia Dhalla; Jennifer Garden; Sylvia Stockler Journal: CNS Neurosci Ther Date: 2016-06-13 Impact factor: 5.243